Save Our Swings

Eric Lefkofsky’s Constant Mission to Improve the Healthcare System

The cost of healthcare has been rising over the past few years, prompting medical researchers to look at the underlying reasons for the continuous rise. Researchers investigating changes in healthcare cost between 1996 and 2013 came up with a conclusion that the higher charges that Americans are experiencing are as a result of specific care that is intense and expensive as opposed to drug or medication prices. Population growth and an increase in the aging population were other factors driving the care cost changes. To be more specific, Americans spent $933 billion in 2013 more than they did in 1996. The researchers opted to break down healthcare cost into specific healthcare spending requirements of various diseases. Top spending drivers differed from one illness to another, for example, diabetes, had different value drivers compared to low back and neck pains.

In the thick and thin of the healthcare wobbles is Eric Lefkofsky who has co-founded a tech company, Tempus, that is working to build the necessary technological infrastructure to standardize and modernize treatment of cancer. Eric Lefkofsky’s venture collects huge amounts of genomic data, and through statistical analysis tools coupled with proprietary algorithms, they unearth opportunities specific to patients enabling physicians to make better and informed treatment decisions. The standardizing of cancer treatment will work in the long run to stabilize health care costs for cancer patients.

Philanthropically, Eric Lefkofsky has donated huge sums of money to charitable causes supporting cancer treatment and research. And in 2006 Eric Lefkofsky teamed up with his wife to establish the Lefkofsky Family Foundation. In its mission, the foundation hopes to support charitable, scientific, and educational organizations and causes across the globe. The foundation avails funds to medical research institutions such as North Shore University Health System in Chicago, Lurie Children’s Memorial Hospital which also hosts Lefkofsky Family Pediatric Intensive Care Unit and the University of Chicago Comer Children’s Hospital. Cancer centers such as American Brain Tumor Association founded by Susan Kramer, Damon Runyon, and Memorial Sloan-Kettering Cancer Center have all been beneficiaries of the Lefkofsky Family Foundation funds. On the global stage, the foundation’s funds causes working to enhance human rights.

To Learn More Click This Link : www.tempus.com/about-us/

Eric Lefkofsky Co-Founder of Data Centric Technology Firm Tempus

Cancer is a disease that has been on the epidemic rise in the last few years, and as per reports around forty percent of United States’ population would suffer some form of cancer during their lifetime. In 2014 alone, there were around 14.5 million U.S. citizens battling cancer. In the next ten years, the figure is expected to reach around twenty million. However, thanks to many technological advances being made in the medical field, many forms of cancer are now recoverable. Moreover, availability and centralization of cancer therapies related data are now possible with the help of efforts made by Tempus; a data centric technology firm co-founded by Eric Lefkofksy. As a noted and successful entrepreneur with plenty of resources to his disposable, Eric Lefkofsky is leaving no stone unturned in ensuring that Tempus can meet its objectives.

Eric Lefkofsky does not have a medical background, and his focus was never to start a company in the medical world until his wife was diagnosed with breast cancer. During the diagnosis of his wife, Eric Lefkofsky realized that there is a significant lack of the availability of cancer treatment related data that would help the oncologists to pinpoint which cancer therapy would be more efficient. It is often seen that some form of therapy is effective on some patient while being completely ineffective on others. Many factors go into play including genomics and the medical history of the patient when deciding upon which cancer treatment to follow for a particular patient. It is what Tempus helps in determining through the data enabled precision medicine. The availability of such data can potentially save lives.

Tempus takes into account the molecular as well as clinical data of the patient and correlates it with the thousands of electronic health records collected from different hospitals and cancer treatment facilities. It helps in coming to a conclusion as to which cancer treatment and medicine would be beneficial for the patient. It reduces the confusion among the oncologists in complicated cases and makes cancer treatment more effective overall. Tempus has also reduced the need for the doctors to follow one size fits all approach when it comes to cancer treatment as each patient is different.

To know more visit @: www.lightbank.com/team/eric-lefkofsky

Scroll To Top